4Filing Date: May 28, 2026

Medtronic (MDT)

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0002061393-26-000008
Total Value$0
Trades2
Insiders1

Transaction Details

Blomquist Denise L.
Chief Accounting Officer·Direct
Exercise · Acquire
Ordinary Shares
Shares+1.71K
Price$0.00
Total Value$0
Shares Owned After14.97K
Transaction DateMay 26, 2026
Footnotes ▸

Represents shares issued upon the settlement of performance-vesting share units granted on July 31, 2023, based on performance as certified on May 26, 2026, of which 1,027 shares will be delivered to the reporting person when her employment with the Company ends.

Blomquist Denise L.
Chief Accounting Officer·Direct
Exercise · Dispose
Performance Share UnitDerivative
Shares-1.62K
Price$0.00
Total Value$0
Shares Owned After0
Transaction DateMay 26, 2026
Footnotes ▸

Each performance share unit represents a contingent right to receive one share of Medtronic common stock. | The performance share units vested on April 24, 2026. | The performance share units vested on April 24, 2026.

Post-Transaction Holdings

Blomquist Denise L. · Chief Accounting Officer
SecuritySharesChange
Ordinary Shares14.97K+1.71K (12.91%)
Performance Share Unit0-1.62K (-100.00%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-05-26 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: Medtronic plc (MDT) CIK: 0001613103 --- Reporting Owner --- Name: Blomquist Denise L. CIK: 0002061393 Role: Officer (Chief Accounting Officer) --- Non-Derivative Transactions --- [Transaction #1] Security: Ordinary Shares Date: 2026-05-26 | Code: M (Exercise of derivative) Shares: +1,712 | Price: $0.00 Shares Owned After: 14,974 | Ownership: D (Direct) Footnotes: [F1] Represents shares issued upon the settlement of performance-vesting share units granted on July 31, 2023, based on performance as certified on May 26, 2026, of which 1,027 shares will be delivered to the reporting person when her employment with the Company ends. --- Derivative Transactions --- [Transaction #1] Security: Performance Share Unit Date: 2026-05-26 | Code: M (Exercise of derivative) Shares: -1,621 | Price: $0.00 Shares Owned After: 0 | Ownership: D (Direct) Footnotes: [F2] Each performance share unit represents a contingent right to receive one share of Medtronic common stock. [F3] The performance share units vested on April 24, 2026. [F3] The performance share units vested on April 24, 2026. --- Footnotes (Complete Index) --- F1: Represents shares issued upon the settlement of performance-vesting share units granted on July 31, 2023, based on performance as certified on May 26, 2026, of which 1,027 shares will be delivered to the reporting person when her employment with the Company ends. F2: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F3: The performance share units vested on April 24, 2026. --- Signature --- /s/ /s/ Patricia Walesiewicz, attorney-in-fact (2026-05-28)

keid analysis is for reference only and does not constitute investment advice.